Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
- 28 May 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 135 (22), 2000-2004
- https://doi.org/10.1182/blood.2019003539
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationCell Reports, 2019
- PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cellsBlood, 2018
- Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCTBlood, 2018
- Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesisLeukemia, 2018
- Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialNature Communications, 2018
- Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCell Stem Cell, 2017
- Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaJournal of Clinical Oncology, 2017
- Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control studyThe Lancet Oncology, 2017
- Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control studyThe Lancet Oncology, 2016
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaNature, 2014